Citigroup
C
Bank of America
BAC
Apple
AAPL
American Express
AXP
Chevron
CVX
US Stock MarketDetailed Quotes
BNTC Benitec Biopharma
- 11.2500
- +1.5500+15.98%
Close Feb 14 16:00 ET
- 11.3500
- +0.1000+0.89%
Post 19:50 ET
261.18MMarket Cap-3.83P/E (TTM)
11.4000High10.2000Low43.20KVolume10.2000Open9.7000Pre Close467.76KTurnover0.34%Turnover RatioLossP/E (Static)23.22MShares13.290052wk High4.07P/B143.92MFloat Cap3.655052wk Low--Dividend TTM12.79MShs Float3939.6222Historical High--Div YieldTTM12.37%Amplitude1.8600Historical Low10.8260Avg Price1Lot Size
Benitec Biopharma News
Benitec Biopharma | SCHEDULE 13G/A: Others
Benitec Biopharma | 8-K: Benitec Biopharma Releases Second Quarter 2025 Financial Results and Provides Operational Update
Benitec Biopharma | 10-Q: Quarterly report
Benitec Biopharma | SCHEDULE 13G/A: Others
Benitec Biopharma | SCHEDULE 13G/A: Others
Benitec Biopharma | 3: Initial statement of beneficial ownership of securities-Officer Mukadam Sophie
Benitec Biopharma | 8-K/A: Current report (Amendment)
Benitec Biopharma | 4: Statement of changes in beneficial ownership of securities-Director SUVRETTA CAPITAL MANAGEMENT, LLC
Benitec Biopharma | 8-K: Current report
Benitec Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Mehta Kishan
Benitec Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Francis Peter
Benitec Biopharma | 4: Statement of changes in beneficial ownership of securities-Director BUCHI J KEVIN
Benitec Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Smith Edward F
Benitec Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Banks Jerel A.
Benitec Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Boston Megan
Benitec Biopharma | 8-K: Current report
Benitec Biopharma | 8-K: Current report
Benitec Biopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Janus Henderson Group plc(11.6%),Janus Henderson Biotech Innovation Master Fund Ltd(8.8%)
Benitec Biopharma | 4: Statement of changes in beneficial ownership of securities-Director SUVRETTA CAPITAL MANAGEMENT, LLC
Benitec Biopharma | 4: Statement of changes in beneficial ownership of securities-Director SUVRETTA CAPITAL MANAGEMENT, LLC
Trending Stocks
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
